These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15658270)

  • 1. [Acyl-coenzyme A: cholesterol acyltransferase (ACAT)].
    Miyazaki A; Watanabe T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():89-91. PubMed ID: 15658270
    [No Abstract]   [Full Text] [Related]  

  • 2. [Roles of acyl-coenzyme A: cholesterol acyltransferase (ACAT) isozymes].
    Miyazaki A; Horiuchi S
    Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):1312-8. PubMed ID: 10397022
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitors of acyl-coenzyme a: cholesterol acyltransferase.
    Miyazaki A; Kanome T; Watanabe T
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):463-9. PubMed ID: 16503866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
    Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin down-regulates acyl-coenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages.
    Furukawa K; Hori M; Ouchi N; Kihara S; Funahashi T; Matsuzawa Y; Miyazaki A; Nakayama H; Horiuchi S
    Biochem Biophys Res Commun; 2004 May; 317(3):831-6. PubMed ID: 15081415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avasimibe Pfizer.
    Burnett JR; Huff MW
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1328-33. PubMed ID: 12498009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions.
    Tardif JC; Grégoire J; L'Allier PL; Anderson TJ; Bertrand O; Reeves F; Title LM; Alfonso F; Schampaert E; Hassan A; McLain R; Pressler ML; Ibrahim R; Lespérance J; Blue J; Heinonen T; Rodés-Cabau J;
    Circulation; 2004 Nov; 110(21):3372-7. PubMed ID: 15533865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets.
    Lee HT; Sliskovic DR; Picard JA; Roth BD; Wierenga W; Hicks JL; Bousley RF; Hamelehle KL; Homan R; Speyer C; Stanfield RL; Krause BR
    J Med Chem; 1996 Dec; 39(26):5031-4. PubMed ID: 8978833
    [No Abstract]   [Full Text] [Related]  

  • 9. Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice.
    Delsing DJ; Offerman EH; van Duyvenvoorde W; van Der Boom H; de Wit EC; Gijbels MJ; van Der Laarse A; Jukema JW; Havekes LM; Princen HM
    Circulation; 2001 Apr; 103(13):1778-86. PubMed ID: 11282910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.
    Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of the ACAT inhibitor avasimibe (CI-1011).
    Llaverías G; Laguna JC; Alegret M
    Cardiovasc Drug Rev; 2003; 21(1):33-50. PubMed ID: 12595916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ACAT inhibitors].
    Miyazaki A; Horiuchi S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():675-80. PubMed ID: 11347152
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of inhibition of acyl coenzyme A-cholesterol acyltransferase (ACAT) on exercise performance in patients with peripheral arterial disease.
    Hiatt WR; Klepack E; Nehler M; Regensteiner JG; Blue J; Imus J; Criqui MH
    Vasc Med; 2004 Nov; 9(4):271-7. PubMed ID: 15678619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
    Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
    Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004.
    Ishii I; Yokoyama N; Yanagimachi M; Ashikawa N; Hata M; Murakami S; Asami Y; Morisaki N; Saito Y; Ohmori S; Kitada M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):115-21. PubMed ID: 9765329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.
    Watanabe T; Nishio K; Kanome T; Matsuyama TA; Koba S; Sakai T; Sato K; Hongo S; Nose K; Ota H; Kobayashi Y; Katagiri T; Shichiri M; Miyazaki A
    Circulation; 2008 Feb; 117(5):638-48. PubMed ID: 18212280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.
    de Medina P; Payré BL; Bernad J; Bosser I; Pipy B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1165-73. PubMed ID: 14617686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lipid-laden foam cell: an elusive target for therapeutic intervention.
    Brewer HB
    J Clin Invest; 2000 Mar; 105(6):703-5. PubMed ID: 10727436
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic?
    López-Farré AJ; Sacristán D; Zamorano-León JJ; San-Martín N; Macaya C
    Cardiovasc Ther; 2008; 26(1):65-74. PubMed ID: 18466422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
    Kitayama K; Tanimoto T; Koga T; Terasaka N; Fujioka T; Inaba T
    Eur J Pharmacol; 2006 Jul; 540(1-3):121-30. PubMed ID: 16730694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.